HLA and prognosis in multiple sclerosis

Journal of Neurology

Volumn 241, Issue 6, 1994, Pages 385-390

  Runmarker, Björn ^a   Martinsson, Tommy ^a   Wahlström, Jan ^a   Andersen, Oluf ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

HLA antigens; Life table analysis; Multiple sclerosis; Prognosis

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; GENE FREQUENCY; HAPLOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; LIFE TABLE; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROGNOSIS; SAMPLING;

AGED; AGED, 80 AND OVER; COHORT STUDIES; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMAN; LIFE TABLES; MULTIPLE SCLEROSIS; PROGNOSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0028337052     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/BF02033356     Document Type: Article

References (38)

1. Joint report (HLA and disease)
2. DNARFLP methods and interpretation scheme for HLA-DR and DQ typing
3. A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10
4. HLA class II genes: typing by DNA analysis
5. HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology
6. HLA antigens and progression of multiple sclerosis. II
7. Clinical subgroups of multiple sclerosis in relation to HLA: DR allelles as possible markers of disease progression
8. A population-based study of multiple sclerosis in twins
9. HLA and heterogeneity of multiple sclerosis
10. Multiple sclerosis in Scotland. An association with HLA-DQw1
11. Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ?
12. Immunogenetic profile of multiple sclerosis in Mexicans
13. HLA-DRß, -DQa, and -DQß restriction fragment length polymorphism in multiple sclerosis
14. HLA-Dwl and BfF as protective markers in multiple sclerosis
15. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course
16. Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and north Europeans
17. On the evaluation of disability in multiple sclerosis
18. Complete amino acid sequence of an HLA-DR antigen-like β-chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens
19. Multiple sclerosis — more than one disease?
20. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes
21. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular study
22. HLA and Japanese MS
23. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation
24. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogentically distinct disease entities
25. HLA in multiple sclerosis
26. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves' disease
27. New diagnostic criteria for multiple sclerosis
28. HLA-antigens and the prognosis of multiple sclerosis
29. Prognosis of multiple sclerosis. Results from an epidemiological area in Germany
30. HLA-typing and lymphocyte population studies in patients with multiple sclerosis
31. Prognostic factors in a multiple sclerosis incidence cohort with 25 years of follow-up
32. Multiple sclerosis: nature or nurture?
33. Detection of specific sequences among DNA fragments separated by gel electrophoresis
34. Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG ind CSF
35. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden
36. Major differences in the dynamics of primary and secondary progressive multiple sclerosis
37. DOß: a new β chain gene in HLA-D with a distinct regulation of expression
38. On estimating the relation between blood group and disease